Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)

McMaster University logo

McMaster University

Status

Terminated

Conditions

Venous Thromboembolism
Fetal Death

Treatments

Other: Thrombophilia Testing

Study type

Observational

Funder types

Other

Identifiers

NCT00149357
CTMG-2005-FLUTE

Details and patient eligibility

About

The purpose of this study is to determine the risk of fetal loss in women with unprovoked venous thromboembolism (VTE) who do not have identifiable inherited thrombophilia compared with women who have the diagnosis of venous thromboembolism (VTE) excluded.

Enrollment

239 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

* Female * At least 18 years of age * Symptomatic for unprovoked venous thromboembolism (deep vein thrombosis \[DVT\] or pulmonary embolism \[PE\]) * At least one pregnancy not terminated intentionally

Exclusion criteria

* Previous VTE in patients with current VTE excluded

Trial design

239 participants in 1 patient group

1, 2 ,3
Description:
Group 1 Women with unprovoked VTE and No Known Thrombophilia Group 2 Women who are investigated for VTE and are negative (Control) Group 3 Women with unprovoked VTE who have Thrombophilia
Treatment:
Other: Thrombophilia Testing

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems